Original Research
Published on 12 Oct 2018
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2018.00452
- 51,001 views
- 118 citations